AC Immune SA - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2834 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

June 2025 Penny Stocks With Promising Potential - Jun 9th, 2025 6:05 am
AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - Apr 30th, 2025 6:15 am
AC Immune: Q1 Earnings Snapshot - Apr 30th, 2025 5:15 am
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - Apr 30th, 2025 5:00 am
Individual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last week - Apr 26th, 2025 6:05 am
AC Immune reports interim outcomes from trial of Parkinson’s therapy - Apr 3rd, 2025 7:46 am
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease - Apr 2nd, 2025 4:00 am
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 - Mar 25th, 2025 5:00 am
ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold? - Mar 24th, 2025 1:00 pm
AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago - Mar 16th, 2025 7:37 am
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update - Mar 13th, 2025 5:00 am
AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know - Mar 5th, 2025 10:00 am
AC Immune to Participate in Upcoming Investor Conferences - Mar 4th, 2025 5:00 am
Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU) - Feb 13th, 2025 7:35 am
3 US Penny Stocks With Market Caps Over $100M To Consider - Feb 3rd, 2025 6:07 am
US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Jan 2nd, 2025 5:07 pm
High Growth Tech Stocks in the United States - Jan 2nd, 2025 11:07 am
AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2 - Dec 11th, 2024 5:26 am
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome - Dec 10th, 2024 5:00 am
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit - Nov 15th, 2024 10:33 am